Tamoxifen and benign endometrial lesions

被引：7

作者：

De Muylder, X ^{[1
]}

Neven, P ^{[1
]}

Van Belle, Y ^{[1
]}

机构：

[1] Clin Gen St Jean, Dept Obstet & Gynaecol, Brussels, Belgium

来源：

EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷

关键词：

D O I：

10.1016/S0959-8049(98)00091-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Benign endometrial lesions are common among breast cancer patients treated with tamoxifen but also among healthy women taking this drug in a breast cancer prevention trial. The most frequent; lesion is glandulocystic atrophy which seems specific for this drug. Endometrial polyps are also very often seen but only a few of them could undergo malignant degeneration. Hyperplasia of the endometrium is more frequently reported among tamoxifen patients than among control patients. (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

页码：S18 / S19

页数：2

共 9 条

[1] CHANGES MIMICKING ENDOMETRIAL NEOPLASIA IN POSTMENOPAUSAL, TAMOXIFEN-TREATED WOMEN WITH BREAST-CANCER - A TRANSVAGINAL DOPPLER STUDY [J].

ACHIRON, R ;

LIPITZ, S ;

SIVAN, E ;

GOLDENBERG, M ;

HOROVITZ, A ;

FRENKEL, Y ;

MASHIACH, S .

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1995, 6 (02) :116-120

[2] ENDOMETRIAL CHANGES WITH TAMOXIFEN - COMPARISON BETWEEN TAMOXIFEN-TREATED AND NONTREATED ASYMPTOMATIC, POSTMENOPAUSAL BREAST-CANCER PATIENTS [J].

COHEN, I ;

ROSEN, DJD ;

SHAPIRA, J ;

CORDOBA, M ;

GILBOA, S ;

ALTARAS, MM ;

YIGAEL, D ;

BEYTH, Y .

GYNECOLOGIC ONCOLOGY, 1994, 52 (02) :185-190

[3] Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: An ultrasound, color flow Doppler, hysteroscopic and histological study [J].

Exacoustos, C ;

Zupi, E ;

Cangi, B ;

Chiaretti, M ;

Arduini, D ;

Romanini, C .

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1995, 6 (06) :435-442

[4] ONCOGENIC POTENTIAL OF TAMOXIFEN ON ENDOMETRIA OF POSTMENOPAUSAL WOMEN WITH BREAST-CANCER - PRELIMINARY-REPORT [J].

GAL, D ;

KOPEL, S ;

BASHEVKIN, M ;

LEBOWICZ, J ;

LEV, R ;

TANCER, ML .

GYNECOLOGIC ONCOLOGY, 1991, 42 (02) :120-123

[5] PATHOLOGY OF ENDOMETRIUM TREATED WITH TAMOXIFEN [J].

ISMAIL, SM .

JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (09) :827-833

[6] EFFECTS OF TAMOXIFEN ON UTERUS AND OVARIES OF POSTMENOPAUSAL WOMEN IN A RANDOMIZED BREAST-CANCER PREVENTION TRIAL [J].

KEDAR, RP ;

BOURNE, TH ;

POWLES, TJ ;

COLLINS, WP ;

ASHLEY, SE ;

COSGROVE, DO ;

CAMPBELL, S .

LANCET, 1994, 343 (8909) :1318-1321

[7]

LAHTI E, 1993, OBSTET GYNECOL, V81, P660

[8]

NEVEN P, 1989, LANCET, V1, P375

[9] LACK OF INDUCTION OF ENDOMETRIAL HYPERPLASIA WITH TAMOXIFEN [J].

TOURAINE, P ;

DRIGUEZ, P ;

CARTIER, I ;

YANEVA, H ;

KUTTENN, F ;

MAUVAISJARVIS, P .

LANCET, 1995, 345 (8944) :254-255

← 1 →